Gastroretentive Drug Delivery Systems Outsourcing Market to Grow with a CAGR of 5.29% through 2028
Increasing demand for targeted drug delivery is expected
to drive the Global Gastroretentive Drug Delivery Systems Outsourcing Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Gastroretentive
Drug Delivery Systems Outsourcing Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Gastroretentive
Drug Delivery Systems Outsourcing Market stood at USD 1.07 billion in 2022 and
is anticipated to grow with a CAGR of 5.29% in the forecast period, 2024-2028. The
global pharmaceutical industry is constantly evolving, seeking innovative
solutions to enhance drug delivery and improve patient outcomes.
Gastroretentive drug delivery systems have emerged as a significant advancement
in this endeavor, allowing drugs to remain in the stomach for an extended
period. This technology not only improves drug bioavailability but also
minimizes side effects and enhances patient compliance. One of the
primary drivers of the gastroretentive drug delivery systems outsourcing market
is the increasing incidence of gastrointestinal disorders worldwide. Conditions
such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS),
and peptic ulcers affect millions of people, necessitating advanced drug
delivery systems that target specific areas of the gastrointestinal tract.
Gastroretentive drug delivery systems provide a viable solution by ensuring
that the drug remains in the stomach, allowing for localized treatment and
controlled release. This trend is spurring pharmaceutical companies to seek
outsourcing services to expedite the development and commercialization of
gastroretentive drug formulations.
The global aging population is another significant
driver of the gastroretentive drug delivery systems outsourcing market. As
people age, they are more susceptible to chronic diseases, including those
affecting the gastrointestinal system. An aging demographic creates a higher
demand for pharmaceutical interventions, making innovative drug delivery
systems more critical. Gastroretentive drug delivery offers the advantage of
providing long-lasting therapeutic effects, which can be particularly
beneficial for the elderly population. Consequently, pharmaceutical companies
are looking to outsource the development of these specialized delivery systems
to cater to this growing demographic.
Patient non-compliance with prescribed medications is
a widespread issue in healthcare. Many patients struggle to adhere to their
medication regimens, often due to the inconvenience and discomfort associated
with conventional drug delivery methods. Gastroretentive drug delivery systems
address this challenge by providing a more patient-friendly and convenient
approach. These systems reduce the frequency of dosing and minimize the need
for strict timing, making it easier for patients to adhere to their treatment
plans. As patient compliance is a critical factor in achieving successful
therapeutic outcomes, pharmaceutical companies are increasingly outsourcing the
development of gastroretentive drug delivery systems to improve patient
adherence and, ultimately, the effectiveness of their drugs.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Gastroretentive Drug Delivery Systems Outsourcing Market"
Outsourcing has become a strategic imperative for
pharmaceutical companies looking to streamline their operations and access
specialized expertise. Developing gastroretentive drug delivery systems
requires a deep understanding of formulation development, regulatory
compliance, and quality assurance. Contract service providers that specialize
in gastroretentive drug delivery can offer end-to-end solutions, including
research and development, clinical testing, and commercial-scale production.
Outsourcing allows pharmaceutical companies to focus on their core competencies
in drug discovery and clinical development while entrusting the specialized
aspects of gastroretentive drug delivery to experienced partners, which can
lead to cost savings and accelerated time-to-market.
The Global Gastroretentive Drug Delivery Systems
Outsourcing Market is segmented into Dosage Form, Regional Distribution, And
Company.
Based on the Dosage Form, Tablets
emerged as the dominant segment in the global market for Global Gastroretentive
Drug Delivery Systems Outsourcing Market in 2022. Tablets are in a solid-state
form, which is ideal for many drug formulations. The solid-state nature allows
for more stable drug storage, longer shelf life, and the inclusion of
controlled-release technologies. For gastroretentive drug delivery, where
controlled and sustained release is often required, the solid format of tablets
is advantageous. Tablets can be formulated in various ways to accommodate
different types of drugs and drug delivery requirements. Gastroretentive
systems can be incorporated into tablet formulations, allowing for
customization of drug release profiles, which is important in achieving
site-specific drug delivery within the gastrointestinal tract.
Tablets are among the most
patient-friendly and convenient dosage forms. They are easy to swallow and do
not involve the discomfort associated with injections or the need for special
administration devices as with liquid formulations. This ease of administration
fosters better patient compliance and encourages pharmaceutical companies to
explore innovative drug delivery systems that can be incorporated into tablets.
Capsule form is the anticipated to rise
in the forecast period creating high demand of Global Gastroretentive Drug
Delivery Systems Outsourcing Market. Capsules offer a versatile
and patient-friendly dosage form that is suitable for various types of drugs,
including those that require controlled release, prolonged action, or
site-specific targeting. Gastroretentive drug delivery systems can be effectively
incorporated into capsule formulations, making capsules an ideal choice for
delivering drugs that need to remain in the stomach for an extended period. Gastroretentive
drug delivery systems, when enclosed within capsules, enable precise targeting
within the gastrointestinal tract. Capsules can be designed to remain in the
stomach or upper intestine, ensuring that the drug is released at the desired
location. This is particularly valuable for medications that require localized
or site-specific action, such as treatments for gastrointestinal disorders.
North America emerged as the dominant
player in the Global Gastroretentive Drug Delivery Systems Outsourcing
Market in 2022, holding the largest
market share. North America is home to a robust and innovative
pharmaceutical industry, with numerous major pharmaceutical companies, biotech
firms, and research institutions based in the United States and Canada. These
companies are actively involved in drug development and seek specialized
outsourcing services for gastroretentive drug delivery systems. Their presence
drives the demand for outsourcing in the region. Regulatory agencies in North
America, particularly the U.S. Food and Drug Administration (FDA), are
well-versed in evaluating and approving complex drug delivery systems. They
have established guidelines and pathways for innovative drug delivery technologies,
providing a regulatory framework that encourages pharmaceutical companies to
invest in gastroretentive drug delivery development and outsourcing.
Major companies operating in Global Gastroretentive
Drug Delivery Systems Outsourcing Market are:
- Catalent Inc.
- Lonza Group
- Evonik
- Colorcon
- Quotient Sciences
- Aptar Pharma
- Aenova Group
- Evotec
- Vectura Group Ltd.
- Ashland.
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The Global Gastroretentive
Drug Delivery Systems Outsourcing Market is poised for significant growth in
the coming years. The advancements in drug delivery technologies, particularly
gastroretentive systems, are driving innovation and spurring pharmaceutical
companies to invest in specialized outsourcing services. The emphasis on
improved patient compliance, personalized medicine, and patient-centric
healthcare further fuels the demand for outsourcing partners with expertise in
gastroretentive drug delivery. Regulatory support and a strong focus on
research and development also play pivotal roles in propelling the market
forward.” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Gastroretentive Drug Delivery Systems
Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Dosage Form (Tablets, Liquid, Microspheres,
Capsule, Others) Region and Competition”, has evaluated the future growth
potential of Global Gastroretentive Drug Delivery Systems Outsourcing Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Gastroretentive Drug Delivery Systems
Outsourcing Market.
Contact
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com